Assembly Biosciences
ASMB
35 hedge funds and large institutions have $50.3M invested in Assembly Biosciences in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
223% more capital invested
Capital invested by funds: $15.5M → $50.3M (+$34.7M)
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
33.92% more ownership
Funds ownership: 16.17% → 50.09% (+34%)
17% more funds holding
Funds holding: 30 → 35 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$468K |
| 2 |
Man Group
London,
United Kingdom
|
+$315K |
| 3 |
PWM
Palumbo Wealth Management
Great Neck,
New York
|
+$184K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$174K |
| 5 |
JP Morgan Chase
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.99M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$943K |
| 3 |
Millennium Management
New York
|
-$569K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$193K |
| 5 |
Amundi
Paris,
France
|
-$114K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NA
26
NewEdge Advisors
New Orleans,
Louisiana
| $13.3K | +$1.35K | +84 | +11% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $5.51K | -$3.85K | -239 | -41% |
|
28
BNP Paribas Financial Markets
Paris,
France
| $4.77K | +$4.86K | +302 | New |
|
29
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $4.1K | +$4.18K | +260 | New |
|
30
RhumbLine Advisers
Boston,
Massachusetts
| $3K | – | – | – |
|
31
Osaic Holdings
Scottsdale,
Arizona
| $2.95K | – | – | – |
|
|
SS
32
SBI Securities
Tokyo,
Japan
| $1.06K | +$1.08K | +67 | New |
|
|
EWA
33
EverSource Wealth Advisors
Birmingham,
Alabama
| $868 | – | – | – |
|
34
Bank of America
Charlotte,
North Carolina
| $584 | -$4.94K | -307 | -89% |
|
|
FFA
35
Frazier Financial Advisors
Columbus,
Ohio
| $17 | – | – | – |
|
|
AI
36
Acuitas Investments
Seattle,
Washington
| – | -$943K | -62,315 | Closed |
|
|
37
Millennium Management
New York
| – | -$569K | -37,553 | Closed |
|
|
38
Citadel Advisors
Miami,
Florida
| – | -$193K | -12,720 | Closed |
|
|
39
Amundi
Paris,
France
| – | -$114K | -7,934 | Closed |
|
40
Lazard Asset Management
New York
| – | -$1K | -71 | Closed |
|
ASMB Hedge Fund Activity: Q4 2024 in Review
35 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2024, worth a combined $50.3M — up 223% from $15.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ASMB positions and 5 closed out — a net gain of 5 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $468K. The largest seller was Armistice Capital, cutting an estimated $2.99M.
- 35 institutional investors held Assembly Biosciences (ASMB) as of Q4 2024, up from 30 in Q3 2024.
- Funds reported $50.3M of Assembly Biosciences stock for Q4 2024, up 223% quarter-over-quarter.
- 10 funds opened new Assembly Biosciences positions in Q4 2024 and 5 closed out, a net change of +5 holders.
- The largest Assembly Biosciences buyer in Q4 2024 was Renaissance Technologies, an estimated $468K added.
- The largest Assembly Biosciences seller in Q4 2024 was Armistice Capital, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2024.